Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Malaysia: TotalEnergies Divests its Minority Non-Operated Interest in Marjoram Gas Field
-
EVE Energy Strengthens European Operations Through Compliance, Local Manufacturing, and Regional Services
-
Sampo appoints Diane Michelberger Head of Investor Relations
-
Telia Lietuva invests EUR 7.1 million to expand 5G and upgrade 500 base stations
-
Michelin: Disclosure of trading in own shares - July 2nd, 2026
-
Invitation to media and analyst briefing for Ericsson Q2 2026 report
-
SKF and Leaderdrive form a venture for precision components in humanoids
-
New release 'Nothing Is Wrong With You' challenges conventional self-help narratives and reclaims personal agency
-
Anoto Proposes New Corporate Identity as INQ Group AB
-
Thor Explorations Ltd.: Director & PDMR Dealing
-
PureTech Founded Entity Celea Therapeutics Completes $180 Million Financing to Advance Deupirfenidone as a Potential New Standard of Care to Treat Idiopathic Pulmonary Fibrosis (IPF)
-
Celea Therapeutics Announces $180 Million Financing to Advance Deupirfenidone as a Potential New Standard of Care to Treat Idiopathic Pulmonary Fibrosis (IPF)
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - July 02
-
Mid-Year Operational and Corporate Update
-
Metapack® Named OneStock's Strategic Delivery Management Partner
-
Braun Launches the Next Generation of Electric Shaver With Braun NEVO Introducing a New Dawn of Smooth Touch
-
Nebius celebrates healthcare and life sciences innovators at expanded AI Discovery Awards
-
CoStar Group Announces Launch of CoStar Platform in France
-
Brenus Pharma Strengthens Its Governance With Designation of a New President and Appointment of Former Novo Nordisk EVP as Independent Member
-
NNS confirms continued support for Rembrandt II
-
OCI N.V. statement regarding Oceanwood Capital
-
Transaction in Own Shares
-
Annual report 2025/26: Bang & Olufsen reports a year of continued transformation, advancing strategic execution and global brand presence during its centenary year
-
NBPE announces Dividend Declaration
-
Abivax Announces Full Exercise of Underwriters’ Option to Purchase Additional ADSs, Bringing Gross Proceeds of Offering to $920M (€807M)
-
ALSTOM S.A: Alstom awarded a new rolling stock order in the AMECA region worth around €800 million
-
NBPE Announces Transaction in Own Shares
-
MAISONS DU MONDE : Filing of the 2025 Universal Registration Document
-
Notice to attend Annual General Meeting in Anoto Group AB (publ)
-
Vopak completes acquisition of majority stake in Green Energy Storage (GES) and takes final investment decision on 200 MW/ 800 MWh battery storage project in the Netherlands
-
DXS INTERNATIONAL PLC (AQSE: DXSP): Trading Update
-
Holding(s) in Company
-
Total Voting Rights
-
Dividend payment ex-date of Aktsiaselts Infortar
-
Qoder Introduces Time-of-Day Credits Pricing for Qwen3.7-Max and Qwen3.7-Plus
-
Skanska rehabilitates Dock Bridge in Newark, New Jersey, USA, for USD 87M, about SEK 810M
-
Ekinops Announces Framework Agreement with Proximus to deploy a nationwide high-speed optical network across Belgium
-
TomTom and Transit Technologies partner to deliver enhanced fleet and logistics operations
-
Bouygues Construction acquires Vannoy Construction, securing lasting presence in the United States
-
Genentech’s Divarasib Shows Superiority in Head-to-Head Phase III Trial Against Approved KRAS G12C Inhibitors in Non-Small Cell Lung Cancer
-
ISS extends and expands partnership with public healthcare provider in Southern Europe
-
Insta and CHAOS Industries Partner to Counter Rising Aerial Threats in Europe
-
Molecular Partners and Orano Med Announce First Patients Dosed in Phase 1/2a Trial of DLL3 Radio-DARPin MP0712
-
WhipNash Brings Exotic Car Rentals to Nashville, With Luxury Vehicles Delivered Directly to Clients at BNA, Hotels, and Events
-
[Ad hoc announcement pursuant to Art. 53 LR] Roche’s divarasib shows superiority in head-to-head phase III trial against approved KRAS G12C inhibitors in non-small cell lung cancer
-
Start of Day Message
-
Novartis receives European Commission approval for Itvisma® for spinal muscular atrophy (SMA)
-
Q3 Fiscal 2026 revenues above expectations; focus on execution
-
LexisNexis Risk Solutions and Promon Align to Strengthen Mobile Fraud Prevention
-
Elicio Therapeutics Announces Pricing of $15 Million Registered Direct Offering
